Influence of antidepressant drugs on macrophage cytotoxic activity in rats

Polish Journal of Pharmacology

Volumn 56, Issue 6, 2004, Pages 837-842

  Belowski, Dariusz ^a   Kowalski, Jan ^a   Madej, Andrzej ^a   Herman, Zbigniew S ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cytotoxic activity; Desipramine; Fluoxetine; Fluvoxamine; Macrophages

Indexed keywords

ANTIDEPRESSANT AGENT; CHROMIUM; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RELEASE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE FUNCTION; MALE; NONHUMAN; RAT; SINGLE DRUG DOSE; SPLEEN; TARGET CELL;

ANIMALS; ANTIDEPRESSIVE AGENTS; DESIPRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FLUOXETINE; FLUVOXAMINE; MACROPHAGES; MALE; RATS; RATS, WISTAR; SPLEEN;

EID: 14244251247     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ader R, Felten D, Cohen N: Interactions between the brain and immune system. Annu Rev Pharmacol Toxicol, 1990, 30, 561-602.
2. Albrecht J, Helderman J, Schlesser M, Rusch A: A controlled study of cellular immune function in affective disorders before and during somatic therapy. Psychiatry Res, 1985, 15, 185-193.
3. Alvarez-Mon M, Kehrl JH, Fauci AS: A potential role for adrenocorticotropin in regulating human B lymphocyte function. J Immunol, 1985, 135, 350-354.
4. Andreoli AV, Keller SE, Rabaeus M, Marin P, Bartlett JA, Taban C: Depression and immunity: age, severity and clinical course. Brain Behav Immun, 1993, 7, 279-299.
5. Baraldi M, Poggioli R, Santi M, Vergoni AV, Bertolini A: Antidepressant and opiates interaction; pharmacological and biochemical evidences. Pharmacol Res Commun, 1983, 15, 843-857.
6. Baumgartner A, Dubeyo M, Campos-Barros A, Eravci M, Meinhold H: Subchronic administration of fluoxetine to rats affects triiodothyronine production and deionization in regions of the cortex and in the limbic forebrain. Brain Res, 1994, 635, 68-74.
7. Biegon A, Samuel D: Interaction of tricyclic antidepressants with opiate receptors. Biochem Pharmacol, 1980, 29, 460-462.
8. Blalock JE: The syntax of immune-neuroendocrine communication. Immunol Today, 1994, 15, 11-18.
9. Bonnet M, Lespinats G, Burtin C: Histamine and serotonin supression of lymphocyte response to phytohemaglutinin and antigen. Cell Immunol, 1984, 83, 280-284.
10. Brady K, Lydiard R, Kellner H, Joffe R, Larid K, Morton A, Steele E: A comparison of the effects of imipramine and fluvoxamine on the thyroid axis. Biol Psychiatry, 1994, 36, 778-789.
11. Carlsson A: Current theories on the mode of action of antidepressant drugs. Adv Biochem Psychopharmacol, 1984, 39, 213-221.
12. Chaput Y, Montigny C, Blier P: Presynaptic and post-synaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacology, 1991, 5, 219-227.
13. Covey S: Depressed mood and development of cancer. Am J Epidemiol, 1991, 134, 324-325.
14. Felten L, Felten Y, Bellinger L, Carlson L, Ackerman D: Noradrenergic sympathetic neural interactions with the immune system. Structure and function. Immunol Rev, 1987, 100, 225-260.
15. Felten Y, Felten L, Bellinger L, Olschowka A: Noradrenergic and peptidergic innervation of lymphoid organs. Neuroimmunoendocrinology, 1992, 52, 25-48.
16. Fridenberg R, Marz J: The effect of lithium carbonate on lymphocyte, granulocyte, and platelet function. Cancer, 1980, 45, 91-94.
17. 1A receptor function. Prog Neuropsychopharmacol Biol Psychiatry, 1989, 13, 445-451.
18. Gordon S, Keshav S, Chung, L: Molecular phagocytes: tissue distribution and functional heterogeneity. Curr Opin Immunol, 1988, 1, 26-35.
19. Haninger R, Charney D: Mechanism of action of anti-depressant treatment. In: Psychopharmacology. The Third Generation of Progress, Raven Press, New York, 1987, 535-542.
20. Johnson. M, Smith M, Torres A, Blalock E: Regulation of the in vitro antibody response by neuroendocrine hormones. Proc Natl Acad Sci USA, 1982, 79, 4171-4172.
21. Kronfol Z, House J: Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls. Acta Psychiatr Scand, 1989, 80, 142-152.
22. Kubera M, Basta-Kaim A, Górka Z: The effect of amitriptyline on the cell-mediated immunity of stressed rats. Pol J Pharmacol, 1995, 47, 137-142.
23. 1A agonist, 8-OH-DPAT, in male rats. Brain Res, 1993, 630, 148-156.
24. Livant S, Felten S, Carlson L, Bellinger L, Felten L: Involvement of peripherial and central catecholamine systems in neuroimmune interactions. J Neuroimmunol, 1985, 10, 5-30.
25. Maj J: Atypical antidepressant drugs - psychopharmacological profile and mechanism of action. Psychopharmacology, 1982, 15, 26-30.
26. Marcinkiewicz J, Ptak W: Macrophage supressor factor in contact sensitivity. Mechanism of its release and action. Immunology, 1980, 41, 211-216.
27. Massie J, Holland C: Depression and cancer patient. J Clin Psychiatry, 1990, 51, 12-17.
28. Nathan C: Secretory products of macrophages. J Clin Invest, 1987, 79, 319-326.
29. Przegaliński E, Jaworska L: The effect of repeated administration of antidepressant drugs on the thyrotropin-releasing hormone (TRH) content of brain structures. Psychoneuroendocrinology, 1990, 15, 147-153.
30. Roszman T, Sparks L, Slevin T, Markesbery R: The presence of serotonin receptors on murine lymphocytes and macrophages. Soc Neurosci Abstr, 1984, 10, 726-738.
31. Steele A, Brahmi Z: Chlorpromazine inhibits human natural killer cell activity and antibody-dependent cell mediated cytotoxicity. Biochem Biophys Res Commun, 1988, 155, 597-602.
32. Stefano B: Role of opioid neuropeptides in immunoregulation. Prog Neurobiol, 1991, 33, 149-159.
33. Stein M, Miller A, Trestman R: Depression, the immune system, and health and illness. Arch Gen Psychiatry, 1991, 48, 171-177.
34. Vetulani J: The development of our understanding of the mechanism of action of antidepressant drugs. Pol J Pharmacol Pharm, 1991, 43, 323-338.
35. Weigent A, Blalock B: Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunol Rev, 1991, 100, 79-108.
36. Wodarz N, Rupprecht R, Kornhuber J, Schmitz B, Wild K, Riedrer P: Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from serve major depressive disorder. J Affect Disord, 1992, 25, 31-38.
37. Wong T, Reid R, Bymaster P, Threlkeld G: Chronic effect of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors. J Neural Transm, 1985, 64, 251-259.